Millions of women barred from hormone therapy due to health risks, including breast cancer survivors

Hormone replacement therapy (HRT) is experiencing a revival as doctors increasingly prescribe it to alleviate menopause symptoms. However, a significant number of women face barriers to accessing this treatment. Millions are unable to take HRT due to underlying health conditions, a critical concern particularly for breast cancer survivors.

Dr. Mindy Goldman, chief clinical officer for Midi Health and a clinical professor at UCSF, highlighted the challenges. She explained that while HRT offers relief for many, specific medical histories and risks exclude a substantial portion of the menopausal population. This creates a difficult situation for women seeking effective symptom management.

“

Hormone replacement therapy is having a resurgence as more doctors prescribe it to treat menopause symptoms.

The resurgence of HRT underscores its recognized benefits, but also brings to the forefront the need for tailored approaches. Ensuring that women can safely access treatments that suit their individual health profiles remains a key challenge in menopause care.

“

But millions of women with menopause can't take HRT due to medical reasons, including breast cancer survivors.